AVASTIN OUEST – Evaluation in usual practice of the bevacizumab–FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006 : focus on resected patients and oncogeriatrics (Article publié dans Oncologie, 2014)

Inscrivez-vous à notre newsletter !